ReviewJournal of diabetes and metabolic disorders2025

Azelnidipine and its role in decreasing urinary albumin creatinine ratio in people with type 2 diabetes and hypertension: a systematic review and meta-analysis.

Jay Tewari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.